Baseline Creatinine Estimation Using Gradient Boosting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for estimating baseline creatinine values, such as the MDRD equation, are inadequate as they do not consider chronic conditions, leading to inaccurate predictions of acute kidney injury (AKI) and potential false positives or negatives in diagnoses.
Innovation Solution
A system and method for determining baseline creatinine values using a trained model that analyzes features like chronic kidney disease status, age, weight, hypertension, and other comorbidities to generate a more accurate creatinine value, employing a gradient boosting regression model for improved prediction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If the MDRD equation is used to estimate baseline creatinine values, then the estimation process is simple and quick, but the prediction accuracy is poor leading to false positives or negatives in AKI diagnosis
Solution Approach 1:
The patent transforms the baseline creatinine estimation problem by changing the input parameters from simple demographics (age, race, gender) to include chronic condition indicators (CKD status, hypertension, nephritis, nephrosis, renal sclerosis, Charlson comorbidity index). This parameter expansion enables the machine learning model to capture patient-specific physiological variations, significantly improving estimation accuracy while maintaining computational feasibility through gradient boosting regression.
2Reliability
If chronic conditions are not considered in the estimation model, then the model is simpler to implement, but the prediction accuracy deteriorates due to inability to account for patient-specific factors
Solution Approach 1:
The patent segments the patient population into distinct groups based on chronic condition status (CKD, hypertension, nephritis, nephrosis, renal sclerosis). By creating separate feature categories for different chronic conditions, the model can systematically account for patient-specific factors without becoming unmanageably complex. This segmentation approach improves AKI diagnosis reliability by capturing heterogeneous patient characteristics while maintaining structured model organization.
3Measurement precision
If a machine learning model is used instead of empirical equations, then the prediction accuracy improves by considering chronic conditions, but the computational resources and training requirements increase
Solution Approach 1:
The patent implements preliminary action by pre-training the gradient boosting regression model on a comprehensive dataset containing patient demographics, chronic conditions, and actual creatinine measurements. This offline training phase captures complex non-linear relationships between chronic conditions and baseline creatinine levels. Once trained, the model can rapidly generate accurate baseline creatinine estimates during clinical use without requiring real-time computational resources for training, thus improving prediction accuracy while minimizing time loss during actual deployment.
Data Source
AI summary
A method (100) for determining a baseline creatinine value for a subject, comprising: obtaining (130) a set of features about the subject; analyzing (140), using a trained baseline creatinine determination model, the obtained set of features to generate a baseline creatinine value for the subject; reporting (150), via a user interface, the generated baseline creatinine value for the subject.